Related Experiment Videos
Bcl-2 expression delays hepatocyte cell cycle progression during liver regeneration
Mary E Vail1, Michelle L Chaisson, James Thompson
1Department of Pathology, University of Washington, Seattle, Washington, WA 98195-7705, USA.
Oncogene
|March 16, 2002
Summary
The anti-apoptotic gene Bcl-2 delays liver tumor development by slowing hepatocyte proliferation. This suggests Bcl-2 influences cell cycle progression, impacting liver regeneration and tumor growth.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Bcl-2 is a key regulator of apoptosis.
- Evidence suggests Bcl-2 also modulates the cell cycle.
- Tumor studies show Bcl-2 expression correlates with better prognosis and reduced proliferation.
Purpose of the Study:
- To investigate if Bcl-2 expression delays liver tumorigenesis by inhibiting hepatocyte proliferation.
- To examine the effect of Bcl-2 on hepatocyte replication during liver regeneration.
Main Methods:
- Studied liver regeneration in Bcl-2 transgenic mice and wild-type littermates.
- Assessed DNA replication timing.
- Analyzed expression of cell cycle regulators like Cyclin D, p107, and Cyclin E/cdk 2 activity.
Main Results:
- DNA replication was delayed by approximately 8 hours in Bcl-2 transgenic mice.
- Cyclin D expression remained unchanged.
- Expression of p107 and Cyclin E, along with Cyclin E/cdk 2 activity, were delayed.
Conclusions:
- Bcl-2 expression delays cell cycle progression in hepatocytes.
- The mechanism appears to involve the cyclin E and p107 pathways.
- Bcl-2's role in delaying liver tumorigenesis may be linked to its effects on hepatocyte replication.